Treatment for Rumination Syndrome
This trial looks at how therapy over video can help reduce worry, rumination, and self-criticism in NYers.
- Rumination Syndrome
- Emotional Distress
Inclusion CriteriaYou will be eligible if you check “Yes” for the criteria below
Study ObjectivesOutcome measures can provide a clearer picture of what you can expect from a treatment.
Awards & Highlights
Find a site
Who is running the clinical trial?
Frequently Asked Questions
Does this trial provide an opportunity for individuals aged 40 and over to participate?
"As stated in the criteria for inclusion, applicants must be aged 18-65 to take part in this clinical trial."
What is the extent of the current sample size involved in this clinical investigation?
"Affirmative. As per the information on clinicaltrials.gov, this medical trial is currently seeking participants and was initially posted on November 1st 2022. In total, 24 individuals are required to be recruited from a single site before data collection can commence."
Are there still vacancies in this clinical research for participants?
"Affirmative, clinicaltrials.gov has data that shows this trial is still recruiting patients since its initial posting on November 1st 2022. The study requires 24 individuals from one site to take part in the experiment."
What is the intended outcome of this research endeavor?
"This clinical trial, to be conducted in a two-week baseline period followed by 12 weeks of treatment and 4 weeks follow-up, will measure the weekly change in attentional control. Secondary goals include assessing changes in anxiety severity with PROMIS Item Bank - Emotional Distress - Anxiety - Short Form 8a (which assigns greater score for higher levels of distress) as well as rumination levels measured by the Rumination-Reflection Questionnaire (RRQ)."